During a 2S-year period 209 dogs with 218 malignant tumours were examined for skeletal metastases. There were 77 malignant tumours without visceral or skeletal metastases. Twenty-four (17%) of the 141 tumours with visceral metastases also had skeletal metastases. Ninety-eight of these tumours were of epithelial origin, and of these 21 (21.4%) had skeletal metastases. In 14 dogs, more than one bone had a metastatic tumour. The humerus, femur and vertebral column were most frequently involved. The lung was the most frequent site of metastatic tumours; then, in order, the liver, kidney and skeleton. The incidence of primary and secondary bone tunours was similar. Metastatic bone disease in the dog is far more common than is generally realized.
Secondary bone tumours can be defined as uni-or multifocal osseous tumours that have disseminated from a primary soft tissue or bone neoplasm elsewhere in the body. Invasion of an adjacent tumour into the surrounding skeleton is generally not considered a secondary bone tumour. Tumours of the haemopoietic and lymphoid tissues, if they occur in the skeleton, usually are classified as primary bone tumours [16, 271. Skeletal metastases in man are often extensive and are probably as frequent as those to the lung and liver [16] . The occurrence in man is between 20 and 70% of all malignant tumours, and carcinomas of the breast, prostate and lungs have the highest incidence [ 171.
Skeletal metastasis in the dog is uncommon [6, 15, 191. Only about 120 cases have been reported and most of these are case reports of one or several cases [ 1, 4, 7-14, 18, 20-23, 25, 26, 28-35] . A few papers report more cases [5, 6, 19, 241 . Information about the frequency of secondary bone tumours in the dog is lacking. There are reports only for mammary gland tumours [24] , osteosarcomas [6] and haemangiosarcomas [5] .
Materials and Methods
During 2% years 2,310 dogs were necropsied and all dogs with malignant tumours were inspected for bone metastases. Dogs with tumours of the haemopoetic and lymphoid tissues or of the central nervous system were not included. From dogs with malignant tumours the vertebral column, pelvic bones, sternum and long bones were cut longitudinally with a band saw and inspected macroscopically for metastases. Ribs were examined grossly and not cut. All suspected lesions were verified with radiological fine structure exposures and with decalcified sections. Osseous tumours were compared with the primary tumours and visceral metastases. Infiltration of tumours into the adjacent skeleton was noted. They were not considered secondary bone tumours.
Results
From the 2,310 dogs, 209 (9.0%) had malignant tumours. In these 209 dogs 218 primary malignant neoplasms were found. Most dogs were killed. The 2 18 tumours were divided in two groups (table I). The primary bone tumours comprised 17 osteosarcomas, four chondrosarcomas, four haemangiosarcomas, and one fibrosarcoma. None of these tumours resulted in skeletal metastasis. There were 10 carcinomas of the nasal cavity, six melanomas of the oral cavity and skin, four squamous cell carcinomas of the oral cavity and skin, two fibrosarcomas, and one each synovial cell sarcoma, neurofibrosarcoma and chemodectoma. In one case there also were skeletal metastases.
The different sites of origin, the histological types and the incidence of osseous metastases of the 141 tumours with visceral metastases are given in table 11. The highest absolute incidence of skeletal metastases was found with tumours of the mammary gland, liver, lung and prostate. The relative numbers of liver and adrenal gland tumours were high.
The epithelial or mesenchymal distribution of the 141 metastatic tumours and the relationship with osseous metastases is given in table 111. Twenty-one of the 24 tumours with skeletal metastases were of epithelial origin. Thus from 98 neoplasms of epithelial origin, 21 resulted in osseous metastasis; the absolute number and percentage of tumours of mesenchymal origin was much lower. In the remaining group of six malignant melanomas and one phaeochromocytoma, there was one primary tumour with osseous metastases. Table IV shows breed, age and sex of the 24 dogs with skeletal metastasis and the location of the primary tumours and the osseous and visceral metastases. Average age of the dogs was 8.7 years. There were 14 females and 10 males.
The frequency of osseous metastasis to various bones is shown in table V. In three of nine dogs metastases were in nearly all vertebrae; in three dogs at least one cervical vertebrae was involved; in two dogs lesions were in the lumbar region; and in one dog only thoracal vertebrae had secondary neoplasms (table IV) .
The number of dogs and the number of bones involved is summarized in table VI. In two dogs most of the skeleton was involved.
In the 141 dogs with metastatic tumours, the lung, which was the most common site for metastatic tumours, had 108 (77.3%). Next was the liver, 35 (24.8%); then the kidneys, 30 (21.3%); and skeleton, 24 (17.0%); in most cases regional lymph nodes were affected.
The number, size and location of the lesions in the long bones were different in each case. Sizes were from hardly visible to one that filled the diameter of the bone.
In most cases metastases were in the cancellous bone of the proximal epiphysis and metaphysis; fewer were in the distal epiphysis and metaphysis and in the diaphyseal marrow cavity. Lesions were extremely rare in the cortical bone, then only by a centrifugal infiltration from surrounding tumour tissue. In most cases there was more than one metastatic tumour in affected bones.
In 15 dogs clinical signs of the secondary osseous tumours did not occur. These lesions varied in size and consisted mainly of intertrabecular growth in the cancellous bone, with only few osteolytic or osteosclerotic changes. Sometimes there were only small tumours in the primary marrow cavity.
In nine dogs clinical signs were referable to one or more osseous metastases. In some of these cases there were obvious radiological changes and at necropsy marked osseous lesions with large osteolytic areas, some endosteal ossification and sometimes periosteal reactions were found. In other cases extensive radiological examination did not show abnormalities; only after scintigraphy was there suspicion of tumour and biopsies confirmed the diagnosis. At necropsy there was mainly large tumour tissue between trabeculae and only histological features of osteolysis.
Discussion
Metastatic skeletal tumours are common in man and are much more numerous than primary bone tumours [15] [16] [17] 271 . Both sarcomas and carcinomas metastasize to the skeleton but carcinomas metastasize more frequently. Over 70% of carcinomas of the breast metastasize to the skeleton, whereas between 20 and 50% of carcinomas of the prostate, lungs and kidney metastasize to bone [16, 171. Reports on the frequency of tumours in dogs are available only for some special types. One report says only four of 180 (2.2%) dogs with primary bone tumours had skeletal metastases [6] whereas another reports metastatic skeletal tumours in 10 (8.8%) of 114 dogs with mammary gland tumours [24]; a third report [5] showed osseous metastases in eight (8.8%) of 106 dogs with haemangiosarcomas.
Secondary bone tumours are not diagnosed as frequently in the dog as in man because often a complete metastatic pattern does not develop before the dog is killed [6, 15, 19, 261 . Also there are less extensive clinical, radiological and postmortem examinations for secondary bone tumours in the dog than in man [6, 15, 19, 261. In the dog many secondary bone tumours are clinically and radiologically misinterpreted as primary bone tumours [6, 191 . Some tumours with a high incidence in man (primary tumours of the lung, prostate, uterus, thyroid, kidney and digestive tract) are far less common in the dog 16, 15, 19, 261. There also may be a difference in the vascular supply of the skeleton and in the biological behaviour of tumours. In man an important way of spread is the vertebral venous system [2, 31. Although the dog has this system [27] there may be differences in the mechanism and extent of vascular invasion or in the venous pressure, or both. This could account for some of the differences in metastatic bone tumour incidence [ 191. In the dogs in this study only tumours with visceral metastasis had skeletal metastasis. As in man [16, 171 most of these tumours were of epithelial origin. The incidence of 21.4% for metastatic carcinomas in my study was higher than that of others [24] who investigated only mammary gland carcinomas. I considered only bone lesions seen macroscopically; these were then verified histologically. The presence of micrometastasis was not evaluated.
My finding that the mammary gland, liver, lung and prostate carcinomas had the highest absolute incidence of secondary bone tumours is in agreement with those of others [6, 15, 19, 271 . The number of liver and adrenal gland tumours is relatively high, but the absolute numbers are too small to draw conclusions.
In my dogs the humerus, femur and vertebrae seemed to be the sites of predilection for metastatic bone lesions. This is in accordance with other reports in dogs [6, 15, 19, 24, 271. In man these sites, together with the pelvic bones, are favoured by secondary bone tumours [ 15-171. The presence of well vascularized red bone marrow in the predilection sites, in contrast with the yellow bone marrow in peripheral bones of the limbs, is probably responsible for the high incidence of metastatic tumours at the predilection sites [27] . It was therefore surprising to find the relative high number for the tibia. As in man [15, 171 prostatic carcinomas had a predilection for the vertebral column. There was no favourite predilection site for metastasis from other specific primary tumours.
Reports [6, 191 show that secondary bone tumours in the dog are far less frequent than primary bone tumours but my research showed the number of primary (26) and secondary (24) bone tumours to be about the same.
The absence of the Boxer breed among the 15 different breeds (table IV) is in contrast with other reports [6] .
Most osseous metastases had an intertrabecular growth. Only in advanced stages was there osteolysis, endosteal and periosteal new bone formation. Advanced stages correlated with clinical signs. In cases without these osseous characteristics but with clinical signs the diagnosis was difficult to make.
From this investigation, I conclude that the incidence of metastatic bone tumours, especially for metastatic carcinomas, is much higher then generally thought. ' Whole vertebral column and ribs were each counted as one bone. 
